Ligand validation:6S6W

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6S6W_NAD_B_601	37%	2%	0.227	0.927	5.44	1.8	17	6	2	0	100%	1
6S6W_NAD_A_601	30%	2%	0.225	0.891	5.46	1.88	18	7	4	0	100%	1
7QK8_NAD_B_1302	73%	65%	0.126	0.955	0.57	0.75	-	2	0	0	100%	0.8532
5FHZ_NAD_C_601	65%	46%	0.171	0.975	0.88	1.24	1	5	3	0	100%	1
6TGW_NAD_A_601	60%	2%	0.164	0.95	5.45	1.99	16	6	1	0	100%	1
6TRY_NAD_B_801	47%	2%	0.193	0.935	5.43	1.93	16	8	2	0	100%	1
6TE5_NAD_B_701	45%	47%	0.191	0.925	0.84	1.24	2	7	5	0	100%	1
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.